View More View Less
  • 1 Pécsi Tudományegyetem, Orvostudományi Kar, Pécs, Édesanyák útja 17., 7624
  • 2 Pécsi Tudományegyetem, Orvostudományi Kar, Pécs
  • 3 Pécsi Tudományegyetem, Orvostudományi Kar, Pécs
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Absztrakt:

A szerzők célja a felnőttkori szolid tumoroknál a műtétre, illetve definitív onkológiai kezelésre való várakozás szerepének tisztázása volt. Ennek érdekében az orvosi szakirodalom áttekintésével, 67 retrospektív vizsgálat, illetve összefoglaló munka elemzésével felmérték az időfaktor, azaz a diagnózist követő kezelésindítás statisztikailag számszerűsíthető hatását a teljes túlélésre. Az időfaktornak biztosan komoly szerepe van a biológiailag agresszívebb betegségeknél, például fiatalkori emlő- és hereráknál vagy fej-nyaki tumoroknál, de az első onkológiai ellátás néhány napos és indokolt megkésése nem negatív hatású a legtöbb szolid daganatos betegségben. A kivizsgálás, illetve a kezelésindítás menetét több orvosi és pszichoszociális tényező alakíthatja, és sokszor éppen a legelőrehaladottabb kórképek ellátása történik meg korábban, inverz túlélési hatást eredményezve. Az onkológiai kezelések eredményességét alapvetően az optimális terápiaválasztás határozza meg, mindazonáltal az időfaktor szerepének megértéséhez feltétlenül további kutatások szükségesek. Orv Hetil. 2018; 159(14): 535–546.

  • 1

    Decree No. 124/2015 (V. 26.) of the Hungarian Government about the modification of the former Government decree No. 43/1999 (III. 3.) on the “Detailed rules of financing healthcare services from the Health Insurance Fund”. [124/2015. (V. 26.) Korm. rendelet az egészségügyi szolgáltatások Egészségbiztosítási Alapból történő finanszírozásának részletes szabályairól szóló 43/1999. (III. 3.) Korm. rendelet módosításáról.] Magyar Közlöny 2015; 71: 6432. [Hungarian]

  • 2

    Moizs M, Ruzsa A, Repa I, et al. Management of cancer patient route in practice. [Onkológiai betegút menedzselés gyakorlati megvalósítása.] IME 2015; 14: 50–54. [Hungarian]

  • 3

    Kásler M, Ottó S, Kenessey I. The current situation of cancer morbidity and mortality in the light of the National Cancer Registry. [A rákmorbiditás és -mortalitás jelenlegi helyzete a Nemzeti Rákregiszter tükrében.] Orv Hetil. 2017; 158: 84–89. [Hungarian]

  • 4

    Mangel L, Kövér E, Szilágyi I, et al. Novel quality assurance method in oncology: the two-level, multi-disciplinary and oncotherapy oncology team system. [Új típusú minőségbiztosítás az onkológiában: a kétlépcsős (multidiszciplináris és onkoterápiás) onkoteamrendszer.] Orv Hetil. 2012; 153: 1984–1991. [Hungarian]

  • 5

    Chen Z, King W, Pearcey R, et al. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008; 87: 3–16.

  • 6

    Biagi JJ, Raphael MJ, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 2011; 305: 2335–2342.

  • 7

    Raphael MJ, Biagi JJ, Kong W, et al. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2016; 160: 17–28.

  • 8

    Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015; 112: S92–S107.

  • 9

    McLaughlin JM, Anderson RT, Ferketich AK, et al. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012; 30: 4493–4500.

  • 10

    Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013; 148: 516–523.

  • 11

    Redaniel MT, Martin RM, Cawthorn S, et al. The association of waiting times from diagnosis to surgery with survival in women with localised breast cancer in England. Br J Cancer 2013; 109: 42–49.

  • 12

    Eastman A, Tammaro Y, Moldrem A, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013; 20: 1880–1885.

  • 13

    Brandão Souza C, Fustinoni SM, Amorim MH, et al. Breast cancer: diagnosis-to-treatment waiting times for elderly women at a reference hospital of São Paulo, Brazil. Cien Saude Colet. 2015; 20: 3805–3816.

  • 14

    Shandiz FH, Janghorban R, Azarkish F, et al. Effect of treatment delay on survival in patients with breast cancer. Online J Health Allied Sci. 2016; 15: 1–4.

  • 15

    Lai R, Hershman DL, Doan T, et al. The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme. Neuro Oncol. 2010; 12: 190–198.

  • 16

    Gliński B, Urbański J, Hetnał M, et al. Prognostic value of the interval from surgery to initiation of radiation therapy in correlation with some histo-clinical parameters in patients with malignant supratentorial gliomas. Contemp Oncol (Pozn). 2012; 16: 34–37.

  • 17

    Seidlitz A, Siepmann T, Löck S, et al. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol. 2015; 10: 172.

  • 18

    Loureiro LV, Victor Eda S, Callegaro-Filho D, et al. Minimizing the uncertainties regarding the effects of delaying radiotherapy for glioblastoma: A systematic review and meta-analysis. Radiother Oncol. 2016; 118: 1–8.

  • 19

    Fortin A, Bairati I, Albert M, et al. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002; 52: 929–936.

  • 20

    Caudell JJ, Locher JL, Bonner JA. Diagnosis-to-treatment interval and control of locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011; 137: 282–285.

  • 21

    van Harten MC, Hoebers FJ, Kross KW, et al. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015; 51: 272–278.

  • 22

    van Harten MC, de Ridder M, Hamming-Vrieze O, et al. The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center. Oral Oncol. 2014; 50: 282–290.

  • 23

    Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016; 34: 169–178.

  • 24

    Sharma S, Bekelman J, Lin A, et al. Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. Oral Oncol. 2016; 56: 17–24.

  • 25

    Liao CT, Chen HN, Wen YW, et al. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma. Eur J Cancer 2017; 72: 226–234.

  • 26

    Cheraghlou S, Kuo P, Judson BL. Treatment delay and facility case volume are associated with survival in early-stage glottic cancer. Laryngoscope 2017; 127: 616–622.

  • 27

    Polesel J, Furlan C, Birri S, et al. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy. Oral Oncol. 2017; 67: 175–182.

  • 28

    Liang H, Xiang, YQ, Lv X, et al. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area. Eur J Cancer 2017; 73: 48–60.

  • 29

    Myrdal G, Lambe M, Hillerdal G, et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004; 59: 45–49.

  • 30

    Yorio JT, Xie Y, Yan J, et al. Lung cancer diagnostic and treatment intervals in the United States: a health care disparity? J Thorac Oncol. 2009; 4: 1322–1330.

  • 31

    Diaconescu R, Lafond C, Whittom R. Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol. 2011; 6: 1254–1259.

  • 32

    Radzikowska E, Roszkowski-Śliż K, Głaz P. The impact of timeliness of care on survival in non-small cell lung cancer patients. Pneumonol Alergol Pol. 2012; 80: 422–429.

  • 33

    Samson P, Patel A, Garrett T, et al. Effects of delayed surgical resection on short-term and long-term outcomes in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2015; 99: 1906–1913.

  • 34

    Gomez DR, Liao KP, Swisher SG, et al. Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol. 2015; 115: 257–263.

  • 35

    Vinod SK, Chandra A, Berthelsen A, et al. Does timeliness of care in non-small cell lung cancer impact on survival? Lung Cancer 2017; 112: 16–24.

  • 36

    Visser E, Leeftink AG, van Rossum PS, et al. Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol. 2016; 23: 2679–2689.

  • 37

    Visser E, van Rossum PS, Leeftink AG, et al. Impact of diagnosis-to-treatment waiting time on survival in esophageal cancer patients – A population-based study in The Netherlands. Eur J Surg Oncol. 2016; 16: 30956–30958.

  • 38

    Brenkman HJ, Visser E, van Rossum PS, et al. Association between waiting time from diagnosis to treatment and survival in patients with curable gastric cancer: A population-based study in the Netherlands. Ann Surg Oncol. 2017; 24: 1761–1769.

  • 39

    Raptis DA, Fessas C, Belasyse-Smith P, et al. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon 2010; 8: 239–246.

  • 40

    Amr B, Shahtahmassebi G, Briggs, CD, et al. Assessment of the effect of interval from presentation to surgery on outcome in patients with peri-ampullary malignancy. HPB (Oxford) 2016; 18: 354–359.

  • 41

    Gort M, Otter R, Plukker T, et al. Actionable indicators for short and long term outcomes in rectal cancer. Eur J Cancer 2010; 46: 1808–1814.

  • 42

    Helewa RM, Turner D, Park J, et al. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival. J Surg Oncol. 2013; 108: 378–384.

  • 43

    Amri R, Bordeianou LG, Sylla P, et al. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014; 21: 3909–3916.

  • 44

    Redaniel MT, Blazeby JM, et al. The association of time between diagnosis and major resection with poorer colorectal cancer survival: a retrospective cohort study. BMC Cancer 2014; 14: 642.

  • 45

    Murchie P, Raja EA, Brewster DH, et al. Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival. Br J Cancer 2014; 111: 461–469.

  • 46

    Nguyen PL, Whittington R, Koo S, et al. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma. Cancer 2005; 103: 2053–2059.

  • 47

    Graefen M, Walz J, Chun KH, et al. Reasonable delay of surgical treatment in men with localized prostate cancer ‒ impact on prognosis? Eur Urol. 2005; 47: 756–760.

  • 48

    Andrews SF, Horwitz EM, Feigenberg SJ, et al. Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma? Cancer 2005; 104: 299–304.

  • 49

    O’Brien D, Loeb S, Carvalhal GF, et al. Delay of surgery in men with low risk prostate cancer. J Urol. 2011; 185: 2143–2147.

  • 50

    Korets R, Seager CM, Pitman MS, et al. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis. BJU Int. 2012; 110: 211–216.

  • 51

    van den Bergh RC, Albertsen PC, Bangma CH, et al. Timing of curative treatment for prostate cancer: a systematic review. Eur Urol. 2013; 64: 204–215.

  • 52

    Redaniel MT, Martin RM, Gillatt D, et al. Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study. BMC Cancer 2013; 13: 559.

  • 53

    O’Callaghan ME, Shi Z, Kopsaftis T, et al. Prostate cancer outcomes and delays in care. Int Urol Nephrol. 2017; 49: 449–455.

  • 54

    Mahmud SM, Fong B, Fahmy N, et al. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol. 2006; 175: 78–83.

  • 55

    Stec AA, Coons, BJ, Chang SS, et al. Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma – does it affect survival? J Urol. 2008; 179: 2152–2157.

  • 56

    Kim KH, You D, Jeong IG, et al. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma. J Cancer Res Clin Oncol. 2012; 138: 1561–1567.

  • 57

    Becker A, Roghmann F, Ravi P, et al. Delay in nephrectomy and cancer control outcomes in elderly patients with small renal masses. Urol Int. 2014; 92: 455–461.

  • 58

    Mano R, Vertosick EA, Hakimi AA, et al. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4 cm. Urol Oncol. 2016; 34: 239.e1–239.e8.

  • 59

    Fradet Y, Aprikian A, Dranitsaris G, et al. Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13(Suppl 3): 37–47.

  • 60

    Jewett M, Rendon R, Dranitsaris G, et al. Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13 (Suppl 3): 54–61.

  • 61

    Bell D, Morash C, Dranitsaris G, et al. Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13(Suppl 3) 30–36.

  • 62

    Saad F, Finelli A, Dranitsaris G, et al. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13(Suppl 3): 16–24.

  • 63

    Perri T, Issakov G, Ben-Baruch G, et al. Effect of treatment delay on survival in patients with cervical cancer: a historical cohort study. Int J Gynecol Cancer 2014; 24: 1326–1332.

  • 64

    Nanthamongkolkul K, Hanprasertpong J. Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival. J Gynecol Oncol. 2015; 26: 262–269.

  • 65

    Shen SC, Hung YC, Kung PT, et al. Factors involved in the delay of treatment initiation for cervical cancer patients: A nationwide population-based study. Medicine (Baltimore) 2016; 95: e4568.

  • 66

    Crawford SC, Davis JA, Siddiqui NA, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 2002; 325: 196.

  • 67

    Yun YH, Kim YA, Min YH, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012; 23: 2731–2737.

  • 68

    Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013; 20: 2468–2476.

  • 69

    Torring ML, Frydenberg M, Hansen RP, et al. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 2013; 49: 2187–2198.

  • 70

    Redaniel MT, Martin RM, Ridd MJ et al. Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink. PLoS ONE 2015; 10: e0126608.

  • 71

    Mathews M, Ryan D, Bulman D. What does satisfaction with wait times mean to cancer patients? BMC Cancer 2015; 15: 1017.

  • 72

    Naghavi AO, Echevarria MI, Strom TJ, et al. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol. 2016; 45: 18–25.

  • 73

    Krokowski E. Duplication time of malignant tumors – Its value for cancer control. Wien Klin Wochenschr. 1965; 77: 258–259.

  • 74

    Tubiana M. Tumor cell proliferation kinetics and tumor growth rate. Acta Oncol. 1989; 28: 113–121.

  • 75

    Wyatt RM, Beddoe AH, Dale RG. The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol. 2003; 48: 139–155.

  • 76

    Molnár IA, Molnár BÁ, Vízkeleti L, et al. Breast carcinoma subtypes show different patterns of metastatic behaviour. Virchows Arch. 2017; 470: 275–283.

  • 77

    Pickering LM, Mahgoub MO, Mukherji D. Is observation a valid strategy in metastatic renal cell carcinoma? Curr Opin Urol. 2015; 25: 390–394.

  • 78

    Comber H, Cronin DP, Deady S, et al. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005; 98: 238–239.

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

Mendeley citation style is available HERE.

 

MANUSCRIPT SUBMISSION

  • Impact Factor (2018): 0.564
  • Medicine (miscellaneous) SJR Quartile Score (2018): Q3
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu